Hepatic venous pressure gradient measurement guiding nonselective beta‐blocker therapy in a patient with clinically significant portal hypertension

Hepatic venous pressure gradient measurement guiding nonselective beta‐blocker therapy in a patient with clinically significant portal hypertension

Abstract Clinically significant portal hypertension (CSPH), defined as a hepatic venous pressure gradient (HVPG) ≥ 10 mmHg, is an independent risk factor for decompensated events in patients with compensated cirrhosis. Currently, the Baveno VII consensus recommends using nonselective beta‐blockers t...

Full description

Bibliographic Details
Main Authors: Kun Wang, Minghui Tian, Linpeng Zhang, Shanghao Liu, Xiaoqing Guo, Jianzhong Ma
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Portal Hypertension & Cirrhosis
Subjects:
Hepatic venous pressure gradient
Non‐selective beta‐blocker
Portal hypertension
Online Access:https://doi.org/10.1002/poh2.47

Internet

https://doi.org/10.1002/poh2.47

Similar Items